Adele F. Holloway

1.5k total citations · 1 hit paper
44 papers, 1.2k citations indexed

About

Adele F. Holloway is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Adele F. Holloway has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 9 papers in Hematology and 9 papers in Immunology. Recurrent topics in Adele F. Holloway's work include Epigenetics and DNA Methylation (11 papers), Genomics and Chromatin Dynamics (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). Adele F. Holloway is often cited by papers focused on Epigenetics and DNA Methylation (11 papers), Genomics and Chromatin Dynamics (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). Adele F. Holloway collaborates with scholars based in Australia, United Kingdom and United States. Adele F. Holloway's co-authors include Joanne L. Dickinson, Ray M. Lowenthal, Farzaneh Atashrazm, GM Woods, Sudha Rao, M Shannon, Adrian K. West, Fiona A. Stennard, Kate H. Brettingham‐Moore and David J. Tremethick and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Adele F. Holloway

43 papers receiving 1.1k citations

Hit Papers

Fucoidan and Cancer: A Multifunctional Molecule with Anti... 2015 2026 2018 2022 2015 50 100 150 200 250

Peers

Adele F. Holloway
Reda Z. Mahfouz United States
Ana Silva Portugal
Karla Queiroz Netherlands
Reda Z. Mahfouz United States
Adele F. Holloway
Citations per year, relative to Adele F. Holloway Adele F. Holloway (= 1×) peers Reda Z. Mahfouz

Countries citing papers authored by Adele F. Holloway

Since Specialization
Citations

This map shows the geographic impact of Adele F. Holloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele F. Holloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele F. Holloway more than expected).

Fields of papers citing papers by Adele F. Holloway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adele F. Holloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele F. Holloway. The network helps show where Adele F. Holloway may publish in the future.

Co-authorship network of co-authors of Adele F. Holloway

This figure shows the co-authorship network connecting the top 25 collaborators of Adele F. Holloway. A scholar is included among the top collaborators of Adele F. Holloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adele F. Holloway. Adele F. Holloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hardy, Kristine, et al.. (2024). RUNX1 regulates promoter activity in the absence of cognate DNA binding motifs. Journal of Cellular Biochemistry. 125(6). e30570–e30570. 1 indexed citations
2.
Holloway, Adele F., et al.. (2022). Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer. Cellular Oncology. 46(2). 239–250. 6 indexed citations
3.
Holloway, Adele F., et al.. (2022). A novel long non-coding RNA regulates the integrin, ITGA2 in breast cancer. Breast Cancer Research and Treatment. 192(1). 89–100. 2 indexed citations
4.
Wilson, A. N., et al.. (2021). Factors affecting paramedicine students’ learning about evidence‐based practice: a phenomenographic study. BMC Medical Education. 21(1). 45–45. 8 indexed citations
5.
Holloway, Adele F., et al.. (2016). The Role of Epigenetic Regulation in Transcriptional Memory in the Immune System. Advances in protein chemistry and structural biology. 106. 43–69. 11 indexed citations
6.
Thomson, Russell, et al.. (2016). Comparison of pre-processing methodologies for Illumina 450k methylation array data in familial analyses. Clinical Epigenetics. 8(1). 75–75. 10 indexed citations
7.
Atashrazm, Farzaneh, Ray M. Lowenthal, GM Woods, et al.. (2015). Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo. Journal of Cellular Physiology. 231(3). 688–697. 43 indexed citations
8.
Taberlay, Phillippa C., Arabella Young, Alison C. West, et al.. (2015). The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1. Journal of Cellular Biochemistry. 117(1). 49–58. 9 indexed citations
9.
Brettingham‐Moore, Kate H., Phillippa C. Taberlay, & Adele F. Holloway. (2015). Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia. Frontiers in Immunology. 6. 499–499. 24 indexed citations
10.
Herbert, Katharine, Adele F. Holloway, Anthony L. Cook, Paulynn Suyin Chin, & Elizabeth T. Snow. (2014). Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytes. Toxicology and Applied Pharmacology. 281(1). 136–145. 25 indexed citations
11.
Young, Arabella, Adele F. Holloway, Nicholas B. Blackburn, et al.. (2014). RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization. BMC Cancer. 14(1). 808–808. 31 indexed citations
12.
James, Sally, et al.. (2010). Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1. Leukemia Research. 34(9). 1203–1213. 17 indexed citations
13.
Brettingham‐Moore, Kate H., et al.. (2008). Determinants of a transcriptionally competent environment at the GM-CSF promoter. Nucleic Acids Research. 36(8). 2639–2653. 15 indexed citations
14.
Holloway, Adele F., et al.. (2007). Targeting Epigenetic Modifiers in Cancer. Current Medicinal Chemistry. 14(24). 2540–2547. 13 indexed citations
15.
Holloway, Adele F., Sudha Rao, Xinxin Chen, & M Shannon. (2003). Changes in Chromatin Accessibility Across the GM-CSF Promoter upon T Cell Activation Are Dependent on Nuclear Factor κB Proteins. The Journal of Experimental Medicine. 197(4). 413–423. 61 indexed citations
16.
Holloway, Adele F., Sudha Rao, & M Shannon. (2002). Regulation of cytokine gene transcription in the immune system. Molecular Immunology. 38(8). 567–580. 52 indexed citations
17.
Holloway, Adele F., et al.. (2000). Functional Interaction between the HIV Transactivator Tat and the Transcriptional Coactivator PC4 in T Cells. Journal of Biological Chemistry. 275(28). 21668–21677. 23 indexed citations
18.
Holloway, Adele F., Fiona A. Stennard, & Adrian K. West. (1997). Human metallothionein gene MT1L mRNA is present in several human tissues but is unlikely to produce a metallothionein protein. FEBS Letters. 404(1). 41–44. 7 indexed citations
19.
Skabo, Stuart J., Adele F. Holloway, Adrian K. West, & Meng Inn Chuah. (1997). Metallothioneins 1 and 2 Are Expressed in the Olfactory Mucosa of Mice in Untreated Animals and during the Regeneration of the Epithelial Layer. Biochemical and Biophysical Research Communications. 232(1). 136–142. 13 indexed citations
20.
Stennard, Fiona A., et al.. (1994). Characterisation of six additional human metallothionein genes. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1218(3). 357–365. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026